XUNFEIHEALTH (02506) released its 2025 interim results on August 20, demonstrating strong financial performance with revenue reaching 298.6 million yuan, representing a 30% year-over-year increase. Gross profit grew 27% to 153.9 million yuan, while maintaining a stable gross profit margin of 51.5%.

The company's hospital solutions have been successfully deployed across more than 500 grade hospitals nationwide. XUNFEIHEALTH has established partnerships with China's leading medical institutions, including West China Hospital of Sichuan University, Qilu Hospital of Shandong University, Beijing Anzhen Hospital, and The First Affiliated Hospital of University of Science and Technology of China, to jointly develop specialized large models for specific diseases and departments. This collaboration is accelerating the release of clinical value.

Additionally, the company's Xinghuo Medical Large Model has been implemented in over 20 leading hospitals across the country. The deep integration of technology with medical scenarios is expected to continue driving long-term business growth.